- Price
- $89.90
- Day
- +0.13%
- Mkt Cap
- $51.76B
- 52W Range
- $72.30 – $96.29
- Volume
- 2.62M
- Beta
- 0.85
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET. Doretta Mistras, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessibl.
Read full article
Beacon Pointe Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 128,603 shares of the medical research company's stock, valued at approximately $11,632,000. A number of
Read full article
Bank of Nova Scotia bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 60,417 shares of the medical research company's stock, valued at approximately $5,465,000. Several other hedge funds also recently made
Read full article
On August 26, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has seen a price performance of +12.4% over the past year
Read full article
EP Wealth Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 37,702 shares of the medical research company's stock, valued at approximately $3,410,000. Other institutional investors and hedge
Read full article
Allworth Financial LP bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 16,600 shares of the medical research company's stock, valued at approximately $1,502,000. A number of other hedge funds have also
Read full article
B. Metzler seel. Sohn and Co. AG acquired a new position in Edwards Lifesciences Corporation (NYSE: EW) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 41,753 shares of the medical research company's stock, valued at approximately $3,777,000. Several other hedge
Read full article
EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.
Read full article
BlackRock Inc. bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 58,789,433 shares of the medical research company's stock, valued at approximately $5,318,092,000. BlackRock Inc. owned approximately 10.21% of Edwards Lifesciences at the end
Read full article
Baxter Bros Inc. purchased a new stake in shares of Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 39,184 shares of the medical research company's stock, valued at approximately $3,545,000. A number of other large investors have
Read full article
Bank Hapoalim BM purchased a new stake in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 19,640 shares of the medical research company's stock, valued at approximately $1,777,000. A number of other large investors
Read full article